Literature DB >> 30499311

Management and outcome of the dislocated hip hemiarthroplasty.

J R Gill1, B Kiliyanpilakkill1, M J Parker.   

Abstract

AIMS: This study describes and compares the operative management and outcomes in a consecutive case series of patients with dislocated hemiarthroplasties of the hip, and compares outcomes with those of patients not sustaining a dislocation. PATIENTS AND METHODS: Of 3326 consecutive patients treated with hemiarthroplasty for fractured neck of femur, 46 (1.4%) sustained dislocations. Of the 46 dislocations, there were 37 female patients (80.4%) and nine male patients (19.6%) with a mean age of 83.8 years (66 to 100). Operative intervention for each, and subsequent dislocations, were recorded. The following outcome measures were recorded: dislocation; mortality up to one-year post-injury; additional surgery; residential status; mobility; and pain score at one year.
RESULTS: Of 43 dislocations, 30 (70%) occurred within one month and 42 (98%) occurred within three months of hip fracture surgery. Seven (16%) of these patients were treated with a single closed reduction and sustained no further dislocations. Four (9%) were treated with open reduction and experienced no further dislocations. Three (7%) hips were left dislocated and the remaining 32 (74%) patients required additional surgery of further closed reduction, revision, or excision arthroplasty. The one-year mortality rates for patients treated with two or fewer reductions (open or closed), successful revision arthroplasty, and excision arthroplasty were 3/14 (21%), 1/7 (14%), and 8/14 (57%) respectively. The only statistically significant difference in mortality was the difference between patients who did not sustain a dislocation and those who did and were treated by excision arthroplasty (p = 0.03). Patients treated by excision arthroplasty had the greatest reduction in mobility scores and highest pain scores. The excision arthroplasty group also included the greatest proportion of patients not able to mobilize and the smallest proportion of patients remaining in their own home.
CONCLUSION: Most dislocations of hemiarthroplasties of the hip occur within one month of surgery. Closed reduction is generally unsuccessful. For those patients with unsuccessful closed reduction, revision arthroplasty should be considered when possible, as this results in a better functional outcome with a lower mortality than excision arthroplasty.

Entities:  

Keywords:  Dislocation; Hip hemiarthroplasty

Mesh:

Year:  2018        PMID: 30499311     DOI: 10.1302/0301-620X.100B12.BJJ-2018-0281.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

1.  Total Hip Arthroplasty for Hip Fracture: Clinical Results and Mid-Term Survivorship.

Authors:  James R Gill; Aly Pathan; Samuel J Parsons; Konrad Wronka
Journal:  Cureus       Date:  2021-12-17

2.  Reply to the Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture Register.

Authors:  Torbjørn B Kristensen; Eva Dybvik; Målfrid Kristoffersen; Håvard Dale; Lars Birger Engesæter; Ove Furnes; Jan-Erik Gjertsen
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

3.  30-day mortality after hip fracture surgery: Influence of postoperative factors.

Authors:  Juan F Blanco; Carmen da Casa; Carmen Pablos-Hernández; Alfonso González-Ramírez; José Miguel Julián-Enríquez; Agustín Díaz-Álvarez
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

4.  Multivariable Analysis of Risk Factors Affecting Dislocation After Bipolar Hemiarthroplasty in Patients with Femoral Neck Fracture.

Authors:  Yuhui Yang; Guangtao Fu; Qingtian Li; Ruiying Zhang; Weihong Liao; Yuanchen Ma; Qiujian Zheng
Journal:  Ther Clin Risk Manag       Date:  2022-02-09       Impact factor: 2.423

5.  Instability after hip hemiarthroplasty for femoral neck fracture: an unresolved problem.

Authors:  Amedeo Falsetto; Johanna Dobransky; Cheryl Kreviazuk; Steven Papp; Paul E Beaulé; George Grammatopoulos
Journal:  Can J Surg       Date:  2022-02-18       Impact factor: 2.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.